These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1184876)

  • 1. Letter: Biosynthetic studies using 13C enriched precursors on the 16-membered macrolide antibiotic leucomycin A3.
    Omura S; Nakagawa A; Takeshima H; Atusmi K; Miyazawa J; Piriou F; Lukacs G
    J Am Chem Soc; 1975 Oct; 97(22):6600-2. PubMed ID: 1184876
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the biosynthesis of 16-membered macrolide antibiotics using carbon-13 nuclear magnetic resonance spectroscopy.
    Omura S; Takeshima H; Nakagawa A; Miyazawa J; Piriou F; Lukacs G
    Biochemistry; 1977 Jun; 16(13):2860-6. PubMed ID: 18162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the biosynthesis of leucomycin, a macrolide antibiotic, by cerulenin.
    Takeshima H; Kitao C; Omura S
    J Biochem; 1977 Apr; 81(4):1127-32. PubMed ID: 881413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioconversion and biosynthesis of 16-membered macrolide antibiotics. XV. Final steps in the biosynthesis of leucomycins.
    Kitao C; Hamada H; Ikeda H; Omura S
    J Antibiot (Tokyo); 1979 Oct; 32(10):1055-7. PubMed ID: 528366
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioconversion and biosynthesis of 16-membered macrolide antibiotic, tylosin, using enzyme inhibitor: cerulenin.
    Omura S; Kitao C; Miyazawa J; Imai H; Takeshima H
    J Antibiot (Tokyo); 1978 Mar; 31(3):254-6. PubMed ID: 649519
    [No Abstract]   [Full Text] [Related]  

  • 6. Chimeramycins: new macrolide antibiotics produced by hybrid biosynthesis.
    Omura S; Sadakane N; Tanaka Y; Matsubara H
    J Antibiot (Tokyo); 1983 Jul; 36(7):927-30. PubMed ID: 6860432
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Application of carbon-13 in biosynthetic studies; FT-13C nuclear magnetic resonance spectra of dihydrolatumcidin.
    Seto H; Sato T; Yonehara H
    J Antibiot (Tokyo); 1973 Oct; 26(10):609-14. PubMed ID: 4792108
    [No Abstract]   [Full Text] [Related]  

  • 8. Biosynthetic origin of carbons 3 and 4 of leucomycin aglycone.
    Omura S; Tsuzuki K; Nakagawa A; Lukacs G
    J Antibiot (Tokyo); 1983 May; 36(5):611-3. PubMed ID: 6874579
    [No Abstract]   [Full Text] [Related]  

  • 9. Hybrid biosynthesis of derivatives of protylonolide and M-4365 by macrolide-producing microorganisms.
    Sadakane N; Tanaka Y; Omura S
    J Antibiot (Tokyo); 1982 Jun; 35(6):680-7. PubMed ID: 7118724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Identification of the antibiotic formed by a Str. canulus 106/78 culture with antibiotic CC-1065].
    Frolova VI; Kuzovkov AD; Chernyshev AI; Taĭg MM; Ivanitskaia LP
    Antibiotiki; 1982; 27(7):483-7. PubMed ID: 7137972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Milbemycins, a new family of macrolide antibiotics. Studies on the biosynthesis of milbemycins alpha 2, alpha 4 and D using 13C labeled precursors.
    Ono M; Mishima H; Takiguchi Y; Terao M; Kobayashi H; Iwasaki S; Okuda S
    J Antibiot (Tokyo); 1983 Aug; 36(8):991-1000. PubMed ID: 6630070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and evaluation of 3,4''-ester derivatives of 16-membered macrolide antibiotics related to tylosin.
    Kirst HA; Debono M; Willard KE; Truedell BA; Toth JE; Turner JR; Berry DR; Briggs BB; Fukuda DS; Daupert VM
    J Antibiot (Tokyo); 1986 Dec; 39(12):1724-35. PubMed ID: 3818446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid biosynthesis of a new macrolide antibiotic by a daunomycin-producing microorganism.
    Sadakane N; Tanaka Y; Omura S
    J Antibiot (Tokyo); 1983 Jul; 36(7):921-2. PubMed ID: 6885644
    [No Abstract]   [Full Text] [Related]  

  • 14. Terminal stages in the biosynthesis of tylosin.
    Seno ET; Pieper RL; Huber FM
    Antimicrob Agents Chemother; 1977 Mar; 11(3):455-61. PubMed ID: 855999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics and biochemistry on tylosin production: a model for genetic engineering in antibiotic-producing Streptomyces.
    Baltz RH
    Basic Life Sci; 1982; 19():431-44. PubMed ID: 6950720
    [No Abstract]   [Full Text] [Related]  

  • 16. The chemistry of leucomycins. VI. Structures of leucomycin A4, A5, A6, A7, A8, and A9.
    Omura S; Katagiri M; Hata T
    J Antibiot (Tokyo); 1968 Apr; 21(4):272-8. PubMed ID: 5671991
    [No Abstract]   [Full Text] [Related]  

  • 17. 13C-NMR evidence for the biosynthetic incorporation of acetate into minimycin and compounds related to Krebs cycle.
    Isono K; Uzawa J
    FEBS Lett; 1977 Aug; 80(1):53-6. PubMed ID: 891969
    [No Abstract]   [Full Text] [Related]  

  • 18. Stimulation of the production of macrolide antibiotics by magnesium phosphate and related insoluble materials.
    Omura S; Tanaka Y; Tanaka H; Takahashi Y; Iwai Y
    J Antibiot (Tokyo); 1980 Dec; 33(12):1568-9. PubMed ID: 7251493
    [No Abstract]   [Full Text] [Related]  

  • 19. Biosynthesis of kitasamycin (leucomycin) by leucine analog-resistant mutants of Streptomyces kitasatoensis.
    Vézina C; Bolduc C; Kudelski A; Audet P
    Antimicrob Agents Chemother; 1979 May; 15(5):738-46. PubMed ID: 525992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioconversion and biosynthesis of 16-membered macrolide antibiotics. XIII. Regulation of spiramycin I 3-hydroxyl acylase formation by glucose, butyrate, and cerulenin.
    Kitao C; Ikeda H; Hamada H; Omura S
    J Antibiot (Tokyo); 1979 Jun; 32(6):593-9. PubMed ID: 468735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.